MiR-122 in hepatic function and liver diseases
暂无分享,去创建一个
Changfei Li | Saifeng Wang | Junli Hao | S. Meng | Changfei Li | Junli Hao | Songdong Meng | Junjie Hu | Yaxing Xu | Jun Hu | Yaxing Xu | Saifeng Wang | Jun Hu
[1] M. Ittmann,et al. Dicer Ablation Impairs Prostate Stem Cell Activity and Causes Prostate Atrophy , 2010, Stem cells.
[2] Xiuming Zhu,et al. MicroRNA‐122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β‐catenin pathway , 2012, Liver international : official journal of the International Association for the Study of the Liver.
[3] S. Monticelli,et al. MiR-146a in Immunity and Disease , 2011, Molecular biology international.
[4] Leina Ma,et al. Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells. , 2010, Cancer biology & therapy.
[5] B. Reinhart,et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans , 2000, Nature.
[6] K. Norman,et al. Modulation of Hepatitis C Virus RNA Abundance and the Isoprenoid Biosynthesis Pathway by MicroRNA miR-122 Involves Distinct Mechanisms , 2009, Journal of Virology.
[7] Ling Zhang,et al. Modulation of the unfolded protein response is the core of microRNA-122-involved sensitivity to chemotherapy in hepatocellular carcinoma. , 2011, Neoplasia.
[8] F. Slack,et al. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy , 2011, Nature Reviews Cancer.
[9] P. Sarnow,et al. Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA , 2005, Science.
[10] N. Rajewsky,et al. Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.
[11] Nan Shen,et al. A Functional Variant in MicroRNA-146a Promoter Modulates Its Expression and Confers Disease Risk for Systemic Lupus Erythematosus , 2011, PLoS genetics.
[12] Stefano Volinia,et al. Interferon modulation of cellular microRNAs as an antiviral mechanism , 2007, Nature.
[13] I. Forgacs. GASTROENTEROLOGY , 1988, The Lancet.
[14] Paul J Rider,et al. A liver‐specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] M. Gazouli,et al. Expression of microRNAs, miR‐21, miR‐31, miR‐122, miR‐145, miR‐146a, miR‐200c, miR‐221, miR‐222, and miR‐223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance , 2013, Molecular carcinogenesis.
[16] A. Velayati,et al. Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection , 2008, Journal of gastroenterology and hepatology.
[17] C. Brander,et al. Host Ethnicity and Virus Genotype Shape the Hepatitis B Virus-Specific T-Cell Repertoire , 2008, Journal of Virology.
[18] S. Hammond,et al. Emerging paradigms of regulated microRNA processing. , 2010, Genes & development.
[19] Mark Graham,et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. , 2006, Cell metabolism.
[20] S. Lemon,et al. Stabilization of hepatitis C virus RNA by an Ago2–miR-122 complex , 2012, Proceedings of the National Academy of Sciences.
[21] W. Filipowicz,et al. The liver-specific microRNA miR-122: biology and therapeutic potential. , 2011, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.
[22] Bing Yu,et al. Construction and identification of a human liver specific microRNA eukaryotic expression vector. , 2007, Cellular & molecular immunology.
[23] C. Esau,et al. Inhibition of microRNA with antisense oligonucleotides. , 2008, Methods.
[24] Michael T. McManus,et al. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity , 2008, The Journal of experimental medicine.
[25] Hui Zhou,et al. Liver‐enriched transcription factors regulate MicroRNA‐122 that targets CUTL1 during liver development , 2010, Hepatology.
[26] C. Croce,et al. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. , 2009, Cancer research.
[27] A. Silahtaroglu,et al. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver , 2007, Nucleic acids research.
[28] Benjamin Israelow,et al. HepG2 Cells Expressing MicroRNA miR-122 Support the Entire Hepatitis C Virus Life Cycle , 2011, Journal of Virology.
[29] Hiroshi Yoshida,et al. Sequencing and Bioinformatics-Based Analyses of the microRNA Transcriptome in Hepatitis B–Related Hepatocellular Carcinoma , 2011, PloS one.
[30] Michael Q. Zhang,et al. Critical roles for Dicer in the female germline. , 2007, Genes & development.
[31] G. Gao,et al. Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G1‐modulated P53 activity , 2012, Hepatology.
[32] Michael D. Wilson,et al. A feedback loop between the liver-enriched transcription factor network and miR-122 controls hepatocyte differentiation. , 2012, Gastroenterology.
[33] A. D’Ambrogio,et al. CPEB and two poly(A) polymerases control miR-122 stability and p53 mRNA translation , 2011, Nature.
[34] A. Xiang,et al. Human Gingiva‐Derived Mesenchymal Stem Cells Elicit Polarization of M2 Macrophages and Enhance Cutaneous Wound Healing , 2010, Stem cells.
[35] M. Siomi,et al. Characterization of the miRNA-RISC loading complex and miRNA-RISC formed in the Drosophila miRNA pathway. , 2009, RNA.
[36] S. Lemon,et al. Regulation of Hepatitis C Virus Translation and Infectious Virus Production by the MicroRNA miR-122 , 2010, Journal of Virology.
[37] H. Bonkovsky,et al. Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes. , 2007, Gastroenterology.
[38] W. Filipowicz,et al. Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy , 2009, Nature Medicine.
[39] A. Fire,et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.
[40] K. Ghoshal,et al. MicroRNA-122 Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells and Sensitizes These Cells to Sorafenib* , 2009, The Journal of Biological Chemistry.
[41] J. Sage,et al. miR than meets the eye. , 2011, Genes & development.
[42] Ryan D. Morin,et al. Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype , 2010, Nature Medicine.
[43] 森田 和豊. Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C , 2012 .
[44] Jinhong Chang,et al. Liver-Specific MicroRNA miR-122 Enhances the Replication of Hepatitis C Virus in Nonhepatic Cells , 2008, Journal of Virology.
[45] S. Kauppinen,et al. LNA-mediated microRNA silencing in non-human primates , 2008, Nature.
[46] Michael Niepmann,et al. microRNA-122 stimulates translation of hepatitis C virus RNA , 2008, The EMBO journal.
[47] M. Lindsay,et al. microRNAs and the immune response. , 2008, Trends in immunology.
[48] M. Elazar,et al. Structural Map of a MicroRNA-122:Hepatitis C Virus Complex , 2011, Journal of Virology.
[49] A. Munnich,et al. miR-122, a paradigm for the role of microRNAs in the liver. , 2008, Journal of hepatology.
[50] Angela M. Liu,et al. microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma , 2010, Molecular systems biology.
[51] Rosa Díaz-Toledano,et al. In vitro characterization of a miR-122-sensitive double-helical switch element in the 5′ region of hepatitis C virus RNA , 2009, Nucleic acids research.
[52] S. Kauppinen,et al. Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection , 2010, Science.
[53] P. Tangkijvanich,et al. Association of HLA‐DRB1*13 and TNF‐α gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population , 2007, Journal of viral hepatitis.
[54] Laura Belver,et al. MicroRNAs prevent the generation of autoreactive antibodies. , 2010, Immunity.
[55] Leina Ma,et al. MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest. , 2011, Cancer letters.
[56] Shi‐Mei Zhuang,et al. A novel GSK‐3 beta–C/EBP alpha–miR‐122–insulin‐like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma , 2010, Hepatology.
[57] Chun-mei Wang,et al. miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3. , 2011, Oncology reports.
[58] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[59] G. Macino,et al. MicroRNAs: novel regulators of immunity. , 2009, Autoimmunity reviews.
[60] S. Thorgeirsson,et al. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties , 2009, Oncogene.
[61] K. Moore,et al. microRNAs and cholesterol metabolism , 2010, Trends in Endocrinology & Metabolism.